Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Mar;75(3):436–440. doi: 10.1136/jnnp.2003.023630

Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi

Y Lo 1, L Chan 1, A Pan 1, P Ratnagopal 1
PMCID: PMC1738963  PMID: 14966161

Abstract

Objective: To prospectively study anti-GQ1b antibody positive cases of acute ophthalmoparesis (AO) clinically and electrophysiologically.

Methods: Nine consecutive cases presenting with predominantly acute ophthalmoplegia were assessed clinically and had stimulated single fibre electromyography (SFEMG) of the orbicularis oculi at presentation. All had magnetic resonance imaging brain scans and anti-GQ1b antibody titres determined.

Results: Four cases had elevated anti-GQ1b antibody titres and abnormal SFEMG studies, which improved in tandem with clinical recovery over three months. Five other anti-GQ1b antibody negative cases were diagnosed as diabetic related cranial neuropathy, idiopathic cranial neuropathy, ocular myasthenia gravis, and Tolosa-Hunt syndrome. All five cases showed complete recovery over a three month period.

Conclusions: This study demonstrated electrophysiologically the dynamic improvement of neuromuscular transmission of anti-GQ1b antibody positive cases of AO, in tandem with clinical recovery. SFEMG is of value in differentiating weakness due to neuromuscular transmission defect from neuropathy in these clinical situations.

Full Text

The Full Text of this article is available as a PDF (199.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchwald B., Bufler J., Carpo M., Heidenreich F., Pitz R., Dudel J., Nobile-Orazio E., Toyka K. V. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology. 2001 Jan 9;56(1):67–74. doi: 10.1212/wnl.56.1.67. [DOI] [PubMed] [Google Scholar]
  2. Buchwald B., Weishaupt A., Toyka K. V., Dudel J. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett. 1995 Dec 8;201(2):163–166. doi: 10.1016/0304-3940(95)12155-2. [DOI] [PubMed] [Google Scholar]
  3. Buchwald Brigitte, Ahangari Raheleh, Toyka Klaus V. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neurosci Lett. 2002 Dec 6;334(1):25–28. doi: 10.1016/s0304-3940(02)01037-6. [DOI] [PubMed] [Google Scholar]
  4. Bullens R. W., O'Hanlon G. M., Goodyear C. S., Molenaar P. C., Conner J., Willison H. J., Plomp J. J. Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle Nerve. 2000 Jul;23(7):1035–1043. doi: 10.1002/1097-4598(200007)23:7<1035::aid-mus5>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  5. Caccavale A., Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol. 2000 Mar;20(1):61–62. doi: 10.1097/00041327-200020010-00018. [DOI] [PubMed] [Google Scholar]
  6. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  7. Farah S., Khuraibet A. J., Montaser M. A., Hussain H. M. Miller Fisher syndrome: unique involvement of ophthalmic division of trigeminal nerve. Clin Neurol Neurosurg. 1995 Nov;97(4):328–331. doi: 10.1016/0303-8467(95)00055-o. [DOI] [PubMed] [Google Scholar]
  8. Goto Y., Hosokawa S., Goto I., Hirakata R., Hasuo K. Abnormality in the cavernous sinus in three patients with Tolosa-Hunt syndrome: MRI and CT findings. J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):231–234. doi: 10.1136/jnnp.53.3.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacobs Bart C., Bullens Roland W. M., O'Hanlon Graham M., Ang C. Wim, Willison Hugh J., Plomp Jaap J. Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome. Muscle Nerve. 2002 Apr;25(4):549–558. doi: 10.1002/mus.10060. [DOI] [PubMed] [Google Scholar]
  10. Krarup C. Electrical and mechanical responses in the platysma and in the adductor pollicis muscle: in normal subjects. J Neurol Neurosurg Psychiatry. 1977 Mar;40(3):234–240. doi: 10.1136/jnnp.40.3.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kuroki S., Saida T., Nukina M., Yoshioka M., Seino J. Three patients with ophthalmoplegia associated with Campylobacter jejuni. Pediatr Neurol. 2001 Jul;25(1):71–74. doi: 10.1016/s0887-8994(01)00281-8. [DOI] [PubMed] [Google Scholar]
  12. Lo Y. L., Ratnagopal P. Transcranial magnetic stimulation studies in the Miller Fisher syndrome: evidence of corticospinal tract abnormality. J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):210–214. doi: 10.1136/jnnp.71.2.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. O'Hanlon G. M., Plomp J. J., Chakrabarti M., Morrison I., Wagner E. R., Goodyear C. S., Yin X., Trapp B. D., Conner J., Molenaar P. C. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain. 2001 May;124(Pt 5):893–906. doi: 10.1093/brain/124.5.893. [DOI] [PubMed] [Google Scholar]
  14. Odaka M., Yuki N., Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):50–55. doi: 10.1136/jnnp.70.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oey P. L., Wieneke G. H., Hoogenraad T. U., van Huffelen A. C. Ocular myasthenia gravis: the diagnostic yield of repetitive nerve stimulation and stimulated single fiber EMG of orbicularis oculi muscle and infrared reflection oculography. Muscle Nerve. 1993 Feb;16(2):142–149. doi: 10.1002/mus.880160204. [DOI] [PubMed] [Google Scholar]
  16. Padua L., Stalberg E., LoMonaco M., Evoli A., Batocchi A., Tonali P. SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol. 2000 Jul;111(7):1203–1207. doi: 10.1016/s1388-2457(00)00307-2. [DOI] [PubMed] [Google Scholar]
  17. Pascual J., Cerezal L., Canga A., Alvarez de Arcaya A., Polo J. M., Berciano J. Tolosa-Hunt syndrome: focus on MRI diagnosis. Cephalalgia. 1999 Dec;19 (Suppl 25):36–38. doi: 10.1177/0333102499019s2509. [DOI] [PubMed] [Google Scholar]
  18. Pullicino P., Beck N. Incremental response to repetitive stimulation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):233–234. doi: 10.1136/jnnp.55.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Roberts M., Willison H., Vincent A., Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet. 1994 Feb 19;343(8895):454–455. doi: 10.1016/s0140-6736(94)92694-8. [DOI] [PubMed] [Google Scholar]
  20. Sauron B., Bouche P., Cathala H. P., Chain F., Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology. 1984 Jul;34(7):953–956. doi: 10.1212/wnl.34.7.953. [DOI] [PubMed] [Google Scholar]
  21. Shibata A., Hosoya T., Kato T., Yuki N., Nagaoka U., Adachi M., Haku T., Yamaguchi K. Abducens nerve enhancement in acute ophthalmoparesis. Radiat Med. 1998 Sep-Oct;16(5):375–377. [PubMed] [Google Scholar]
  22. Slater C. Double agents and breakdown of integrity at the neuromuscular junction in Miller-Fisher syndrome. Brain. 2001 May;124(Pt 5):847–848. doi: 10.1093/brain/124.5.847. [DOI] [PubMed] [Google Scholar]
  23. Sonoo M., Uesugi H., Mochizuki A., Hatanaka Y., Shimizu T. Single fiber EMG and repetitive nerve stimulation of the same extensor digitorum communis muscle in myasthenia gravis. Clin Neurophysiol. 2001 Feb;112(2):300–303. doi: 10.1016/s1388-2457(00)00544-7. [DOI] [PubMed] [Google Scholar]
  24. Tanaka H., Yuki N., Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol. 1998 Aug;126(2):322–324. doi: 10.1016/s0002-9394(98)00161-5. [DOI] [PubMed] [Google Scholar]
  25. Uncini A., Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve. 1999 May;22(5):640–644. doi: 10.1002/(sici)1097-4598(199905)22:5<640::aid-mus14>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  26. Wessig C., Buchwald B., Toyka K. V., Martini R. Miller Fisher syndrome: immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction. Acta Neuropathol. 2001 Mar;101(3):239–244. doi: 10.1007/s004010000285. [DOI] [PubMed] [Google Scholar]
  27. Winer J. B. Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):433–435. doi: 10.1136/jnnp.71.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yousem D. M., Atlas S. W., Grossman R. I., Sergott R. C., Savino P. J., Bosley T. M. MR imaging of Tolosa-Hunt syndrome. AJR Am J Roentgenol. 1990 Jan;154(1):167–170. doi: 10.2214/ajr.154.1.2104703. [DOI] [PubMed] [Google Scholar]
  29. Yuki N., Odaka M., Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology. 2001 Jan;108(1):196–200. doi: 10.1016/s0161-6420(00)00420-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES